![](https://www.cidrap.umn.edu/sites/default/files/styles/layout_large/public/article/syringe%20and%20vial.jpg?itok=NCI3eHAw)
HHS awards Moderna $176 million to develop mRNA H5 avian flu vaccine
The US Department of Health and Human Services (HHS), through its Biomedical Advanced Research and Development Authority (BARDA), today announced that it has awarded Moderna $176 million to develop a prepandemic vaccine against H5 avian influenza. In its …